Introduction
The conventional surgical therapy of thoracoabdominal aneurysms still includes high mortality and morbiditiy rates despite it is the gold standard treatment modality of this pathology1. Even hybrid approaches have some risks, the technique reduces the mortality and morbidity rates especially in high risk patients2.
Hybrid repair involves endovascular aortic repair following debranching of the cervical or the visceral arteries2. In the treatment of zone 2 thoracic endovascular aortic repair, revascularization of the left subclavian artery (LSA) decreases the ischemic complications such as stroke, spinal cord ischemia, and upper extremity ischemia as well as LSA related type 2 endoleaks3. Also, in the case of the presence of aberrant right subclavian artery (ARSA), the embolization of ARSA is necessary to prevent endoleak when TEVAR is performed following debranching4.
In this report, we present our subclavian artery revascularization with a cross over axilloaxillary bypass in the patients with thoracic aortic aneurysm who underwent hybrid repair.
Patients and methods
Between May 2015-December 2018, 4 patients underwent TEVAR procedure following axilloaxillary bypass grafting. Patients had thoracic aortic aneurysms comprising the LSA or aberrant right subclavian artery. The patients who underwent conventional open surgical repair or full endovascular interventions were excluded from the study. The mean age of the patients 72.5 ± 3.01 years (range: 64-78, median: 74).
The first patient was 64 year old female patient. She presented to the clinic with difficulty while swallowing. She had hypertansion. Computed tomography angiography revealed aberrant right subclavian artery aneurysm compressing esophagus together with thoracic aortic aneurysm.
The 75 year old male patient with diabetes mellitus and anemia presented to the clinic with an aneurysmatic dilatation arising from origin of the aberrant right subclavian artery to the thoracic artery (Fig. 1). The patient had also infrarenal abdominal aortic aneurysm.
The 73 year old male patient had a history of previous TEVAR and EVAR. The control computed tomography angiography revealed new ulcerated aortic plaque at the level of left subclavian artery origin and no flow in the right common and external iliac artery. He had diabetes mellitus, gastritis, gastroesophageal reflux disease, hypertension and the history of cerebrovascular event.
The 78 year old male patient had thoracic aortic aneurysm and dissection (Fig. 2). He had coronary artery disease and he was on dialysis 3 days a week through left radiocephalic fistula.
The patients were evaluated and hybrid repair was planned due to their poor conditions and additonal pathologies such as aberrant right subclavian artery aneurysm. All patients underwent endovascular stent graft repair following axilloaxillary bypass grafting in the same day.
100 mg of aspirin and 75 mg of clopidogrel were prescribed to the patients for 3 months. After 3 months the patients were treated with single antiplatelet therapy life long. At least 20 mg of atorvastation was added to the medical therapy for 1 year and it is continoued depending on the cholesterol levels in the long term.
Surgical technique and endovascular stent graft repair
Bilateral axillary arteries were dissected through infraclavicular incisions with general anesthesia. Following systemic 5,000 units of heparin, an 8mm subfascially placed ringed PTFE graft was interposed between the bilateral axillary arteries. Depending on the pathology either the LSA or ARSA was proximally ligated.
For the TEVAR procedures, the right femoral artery was dissected surgically. Superstiff 0.035-inch guidewire (Back-up Meier, Schneider Co.; Blach, Switzerland) was inserted at the ascending aorta through the arteriotomy. A 5F sheath was inserted percutaneously to the left femoral artery to provide directing a 5F pigtail catheter for angiographic monitoring. Following systemic heparinization (5000 U), longitudinal incision was performed in the right common femoral artery and endovascular stent graft delivery system (Endurant Medtronic Endovascular, Santa Roja, CA, USA) was positioned at the thoracic aorta. Then the stent graft was then expanded. The stent graft covered the left subclavian artery in 2 cases and the aberrant subclavian artery orifice in 2 cases. The femoral artery was reconstructed primarily or with a patch when needed.
Results
Mortality did not occur in the perioperative period. All patients were extubated when they were taken to the intensive care unit. Mean intensive care unit stay was 1.75 ±0.48 days (range: 1-3, median: 1.5). All patients underwent endovascular stent graft repair following axilloaxillary bypass grafting in the same day. Bleeding or hematoma did not occur in any patients. Mean hospital stay was 4.7 ±0.45 days (range: 4-6, median: 4.5).
The 64 year old female patient with aberrant right subclavian artery underwent axilloaxillary bypass grafting operation. Following the procedure, the patient was taken to the invasive radiology department. The aberrant right subclavian artery was coiled to prevent retrograde endoleak and the stent graft was inserted from distal of the left subclavian artery orifice to mid portion of thoracic aorta (Fig. 3). The postoperative course was uneventful.
The 75 year old male patient underwent the aberrant right subclavian artery coiling to prevent retrograde endoleak and the stent graft was inserted from distal of the left subclavian artery orifice to mid portion of thoracic aorta, following axilloaxillary bypass grafting. In another session, endovascular aortic stent graft repair was performed to treat infrarenal abdominal aortic aneurysm.
The 73 year old male patient with a history of previous TEVAR and EVAR underwent TEVAR extension to the proximal portion of aorta by covering the left subclavian artery origin following axilloaxillary bypass grafting. Cross femoral bypass grafting was performed in the same session with TEVAR extension to treat right external and common iliac artery occlusion.
The 78 year old male patient with thoracic aortic aneurysm and dissection underwent thoracic endovascular stent graft repair by covering the left subclavian artery origin after axilloaxillary bypass grafting (Fig. 4).
In the early period (30 days) of the operation, the mortality or complication did not occur in any patients. The 78 year old patient with chronic renal insufficiency and coronary artery disease presented with graft infection in the 8th month of the operation. The patient had left radiosephalic fistula and the permanent dialysis catheter was inserted in the right subclavian artery due to inappropriate flow of the fistula. The patient underwent graft excision but in the early period of the operation, he was lost due to pneumonia in the intensive care unit.
The control computed tomographies of the other 3 patients revealed patent grafts together with successful endovascular interventions and they have been following uneventfully a mean of 27 ± 6.2 months (range: 24-32, median: 29).
Discussion
Thoracic endovascular aortic repair (TEVAR) has become standard treatment option for the suitable patients with descending thoracic aortic pathologies in the current era. However, up to one third of these patients require overlapping of the LSA due to involvement of LSA origin in the aortic pathology for an uneventful and succesful procedure3.
Although revascularization of the LSCA was recommended as mandatory in the first years of endovascular stent graft repair in the aortic arch, it was thought that it was not necessary due to appropriate collateral flow in later years5. Recently, the Society for Vascular Surgery and the European Society for Vascular Surgery recommended routine revascularization of the left subclavian artery in elective patients and selective patients with emergent conditions3. The revascularization may be performed after TEVAR in urgent cases6. However, the advices of SVS were based on low quality evidence6. The revascularization is mandatory in patients with left internal mammary coronary artery bypass graft, arterial-venous fistula, or dominant left vertebral artery3.
The risk of stroke, spinal cord ischemia, and upper extremity ischemia are reported to be higher in the patients who underwent coverage of the LSA without revascularization in the literature6. Left subclavian artery revascularization techniques include surgical and endovascular measures such as LSA to carotid transposition (SCT) or carotid-subclavian bypass (CSB), chimney/snorkel grafting, branched/fenestrated endografts, and creation of insitu fenestration. The advantage of endovascular techniques is elimination of left carotid artery manupilation3. The axilloaxillary artery bypass grafting technique has certain unique advantages. The most effective and optimal revascularization technique of LSA is still unclear in literature3,6.
Aberrant right subclavian artery is the most common aortic arch pathology with 0.5%–2.0% incidence in population7,8. In patients who have ARSA together with thoracoabdominal aneurysms ARSA embolization is necessary to prevent endoleak whom receive TEVAR4. Also, the ARSA should be revascularized to prevent ischemic complications in the upper limbs or vertebrobasilar area and the risk of aneurysmal dilatation and rupture8.
Limitations
Small number of patients and retrospective nature of the study are major limitations of the study.
Conclusion
We preferred axilloaxillary bypass to revascularize the LSA or ARSA in our patients. All our patients had certain risks due to older age and comorbidities for conventional thoraci aneurysm repair. The axilloaxillary artery bypass technique prevented the manupilation and clamping of the carotid artery as during carotid-subclavian bypass or transposition. The long term patency rates had been promisin. Hence, especially in the patients with certain comorbidities, the revascularization of subclavian artery may be provided with a crossover axillary artey bypass. The technique is simple, durable and prevents the risks due to carotid artery involvement during the surgical therapy.